Skip to main content

Dr. Eric L. Wallace, D.O.

Interventional Cardiology (Interventional Cardiology Physician)

  • Medicare participating

At a glance

Years since graduation
20
In the NPI registry since
2007
Medicare patients seen, 2024
1,961

Licensed in Washington since 2014, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Interventional Cardiology Physician primary
    ID license O-0839 · WA license OP60505950 (first issued 2014; expired)
  • Cardiovascular Disease Physician
    ID license O0839
  • Internal Medicine Physician
    KY license 03263 · NC license 2007-014326

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Interventional Cardiology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
1,961
Services billed
3,975
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only688611
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function622609
Established patient office or other outpatient visit, 30-39 minutes403368
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes15784
Ultrasound of both sides of head and neck blood flow120119
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician100100
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes10097
Nuclear medicine studies of heart muscle at rest and with stress and spect8686
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician8585
Ultrasound of heart with color-depicted blood flow, rate and valve function8181

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 6 companies reported 11 payments worth $341 in total to this clinician.

By type
Food and Beverage$341

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Idaho →

Industry-funded research

Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $44,032 in research payments for these studies, mostly to the institutions running them.

  • EASi-HF A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in partici…
    Boehringer Ingelheim International GmbH
  • EASi-HF A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in partici…
    Boehringer Ingelheim Pharma GmbH & Co.kg
  • SIMPLAAFY Clinical Trial
    Boston Scientific Corporation · Active, not recruiting · NCT06521463
  • A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)
    Janssen Research & Development, LLC

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Interventional Cardiology clinicians in Coeur D Alene

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 25, 2025), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1568658243. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.